Name | ONO AE3 208 |
---|---|
Supplier | Tocris Bioscience |
Catalog | 5406 |
Prices | $195.00, $805.00 |
Sizes | 10 mg, 50 mg |
Function Type | Antagonist |
Cas Number | 402473-54-5 |
Chemical Name | 4-Cyano-2-[[2-(4-fluoro-1-naphthalenyl)-1-oxopropyl]amino]benzenebutanoicacid |
Formula | C24H21FN2O3 |
Molecular Weight | 404.43 |
Purity | >98 % |
Description | High affinity and selective EP 4 receptor antagonist (K i values are 1.3, 30, 790 and 2400 nM for EP 4 , EP 3 , FP and TP receptors respectively). Displays no affinity for EP 1 , EP 2 , DP or IP receptors (K i >10 μ M). Inhibits PGE 2 -induced IL-8 production in colonic epithelial caco-2 cells and attenuates PGE 2 inhibition of natural killer T cell activation. Suppresses recovery from experimentally-induced colitis and stimulates CD4 + T cell proliferation in C57BL/6 mice. Also reduces metastasis of mammary tumor cells in a murine model of breast cancer. Orally active. |
Supplier Page | Shop |
Kabashima K, Saji T, Murata T, Nagamachi M, Matsuoka T, Segi E, Tsuboi K, Sugimoto Y, Kobayashi T, Miyachi Y, Ichikawa A, Narumiya S. J Clin Invest. 2002 Apr;109(7):883-93.
Ma X, Kundu N, Rifat S, Walser T, Fulton AM. Cancer Res. 2006 Mar 15;66(6):2923-7.
Dey I, Giembycz MA, Chadee K. Br J Pharmacol. 2009 Feb;156(3):475-85.
Deng ZB, Zhuang X, Ju S, Xiang X, Mu J, Liu Y, Jiang H, Zhang L, Mobley J, McClain C, Feng W, Grizzle W, Yan J, Miller D, Kronenberg M, Zhang HG. J Immunol. 2013 Apr 1;190(7):3579-89.